Xcout Intel
Remepy competitors & alternatives
The 12 closest competitors and alternatives to Remepy among biotech companies — ranked by similarity to what Remepy actually does, not by market-cap band.
Subscribe to see Remepy’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Remepy
Remepy is a biotechnology research company headquartered in New York, NY, that pioneers hybrid drugs combining traditional pharmaceutical medications with targeted digital therapeutics.
Remepy at a glance
Remepy is a biotech company headquartered in New York, United States, founded in 2022. It has raised at least $46M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $36M in August 2026. Xcout tracks 17 named people at Remepy, including Michal Tsur (CEO).
Remepy leadership
- Michal TsurCEO
- Nora SipermanChief Financial Officer
- Eran EtamChief Technology Officer
- Renan GutmanChief Product Officer
- Dr. Nira SaportaChief Therapeutics Officer
- Lisa BennettChief Marketing Officer
11 more named people on record for Remepy, with roles, board committees and tenure — see the full roster →
Remepy funding rounds
At least $46M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $36M | 12 named | |
| Seed | $10M | 6 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Remepy news
Top 12 Remepy competitors
Ranked by semantic similarity — how close each company is to Remepy by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
RonanRx Inc. is a health tech startup backed by Y Combinator based in San Francisco, helping patients personalize GLP-1 treatments like Ozempic and peptides.
Underrepresented Healthcare
Essara Health builds digitally enhanced pharmaceuticals, medical-grade wearables, and licensed software-as-a-medical-device (SaMD) personalized patient experiences. The healthcare technology company is headquartered in Ernakulam, Kerala, India.
Biotechnology
Remedy Plan, Inc. is a Maryland-based biotechnology holding company founded in 2011 that focuses on drug pipelines, patents, and clinical trials.
Biotechnology
AtaiBeckley Inc. has its corporate headquarters located in New York, USA. The biopharmaceutical company is on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
Biotechnology
metaMe Health, Inc. is a digital health company that launched recently-approved prescription digital therapeutics such as Regulora.
Biotechnology
Memgen, Inc. is a biotechnology research company focused on drug pipelines and science development programs, headquartered in Houston, Texas.
Similar biotech company
Remix Therapeutics, Inc. is a biotechnology company headquartered in Watertown, Massachusetts. The company specializes in developing novel therapies that alter RNA processing to address serious diseases.
Similar biotech company
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York.
Biotechnology
Imagine Pharma LLC is a biotechnology company that develops novel polypeptide-based platforms focused on oral delivery for biologic drugs, therapeutics for various disease states, and regenerative medicine. The company aims to create first-in-class treatments for conditions such as diabetes and wound healing, alongside offering oral peptide dietary supplements and functional ingredients for consumers.
Biotechnology
Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.
Biotechnology
Syremis Therapeutics Ltd. is a clinical-stage biopharmaceutical company headquartered in Tel Aviv, Israel, dedicated to developing novel drug pipeline medicines targeted at treating diseases of the nervous system and mental health disorders.
Similar biotech company
Panther Life Sciences is a privately held biotechnology company founded in 2023 and headquartered in New York, NY. The company licenses and develops new treatments utilizing dissolvable microarray patch (MAP) technology to deliver shelf-stable medicine through the skin.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Remepy and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Remepyand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →